MYC and breast cancer: Skp2 is a ubiquitin ligase of Myc, which promotes the polyubiquitination and degradation of Myc during normal lymphocytes G1 to S phase transition [145], and USP22 mediates the deubiquitination of c-Myc to promote breast cancer progression [146].